)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
APT Medical
APT Medical (688617) investor relations material
APT Medical Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary28 Oct, 2026
Executive summary
Q3 revenue rose 27.24% YoY to RMB 831.7m; attributable net income increased 41.76% to RMB 280.9m, supported by sales growth, stronger product profitability and cost controls.
9M revenue increased 26.27% YoY to RMB 2.358bn and attributable net income rose 31.27% to RMB 818.2m.
Financial highlights
Q3 total profit was RMB 329.2m, up 45.39% YoY; net income attributable to shareholders excluding non-recurring items was RMB 277.4m, up 44.95%.
9M total profit reached RMB 932.4m, up 32.11%; adjusted attributable net income was RMB 806.2m, up 33.87%.
9M operating cash flow increased 40.26% YoY to RMB 948.2m; higher cash receipts from sales of goods and services were cited as the main driver.
Key financial ratios and metrics
Basic EPS was RMB 2.05 in Q3, up 45.39% YoY, and RMB 5.87 for 9M, up 32.81%.
9M weighted average ROE was 25.95%, up 3.54 percentage points YoY; diluted EPS was RMB 5.87 versus RMB 4.41 in 9M 2025.
9M R&D spending was RMB 315.2m, up 23.56%; R&D was 13.37% of revenue, down 0.29 percentage points YoY.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from APT Medical
- H1 2026 revenue and profit rose over 25% year-over-year, with strong growth in core segments.688617
Q2 2026 - Net profit rose 33% on 27% revenue growth, with strong R&D and market expansion.688617Q2 2024
- Revenue and net profit surged over 25% year-over-year, with strong R&D and global expansion.688617Q4 2024
- Q3 revenue and net profit rose over 20% year-over-year, with strong adjusted profit growth.688617Q3 2024
- H1 2025 revenue and profit surged over 20% year-over-year, with robust growth across all segments.688617Q2 2025
- Q1 2025 revenue and net profit surged over 20% year-over-year, with robust cash flow growth.688617Q1 2025
- 2025 revenue up 25.08% and net profit up 21.91%, with strong R&D and global expansion.688617Q4 2025
- Revenue up 22.47% and net profit up 18.02% year-over-year, with strong cash flow and R&D growth.688617Q3 2025
- Revenue and net profit surged over 24% year-over-year, with EPS up 26.15% in Q1 2026.688617Q1 2026
Next APT Medical earnings date
Q4 202625 Mar, 2027
APT Medical
Next APT Medical earnings date
Q4 202625 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)